Adma Biologics Inc (ADMA)

EBITDA Growth

26.04%

Quarterly · Period ending:

ADMA logo

ADMA EBITDA Growth

Year-over-year change vs the same period a year earlier

Latest reported26.04%
ADMA Quarterly EBITDA YoY % (-37288.54% → 26.04%)
High-resolution chart · PNG

ADMA ebitda growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Adma Biologics Inc EBITDA Growth — Quarterly
Period endingEBITDA Growth
26.0361%
63.3043%
65.0825%
21.3923%
5.5373%
53.9862%
524.1729%
281.6192%
1,957.305%
1,686.9021%
-104.4982%
248.2471%
127.1305%
106.7853%
61.4264%
42.6025%
47.8978%
-43.5273%
21.5708%
-1.5726%
11.664%
11.3394%
-115.1782%
-60.4702%
-57.0194%
-46.7928%
55.3362%
38.1425%
17.6161%
31.5731%
-52.4929%
5.1365%
-54.5267%
-170.1455%
-169.5959%
-276.4919%
-51.0159%
-44.0501%
4.9931%
20.6391%
-52.842%
-30.5139%
-11.1102%
-52.3506%
1.9712%
45.2557%
19.1312%
-20.5162%
23.2827%
-83.6184%
-27.4085%
8.6526%
-303.9745%
-164.4299%
-41,991.4636%
-52,279.2077%
-9,809.2971%
-23,539.5112%
-59.2848%
-11.4341%
-54.2453%
-2.0578%
-20.8459%
99.8784%
99.9622%
99.956%
99.9392%
19.6135%
31.9248%
36.4488%
16.1552%
24.1169%
41.3508%
-37,288.535%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.